umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology.
Show others and affiliations
2004 (English)In: Eur J Cancer, ISSN 0959-8049, Vol. 40, no 1, p. 33-42Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 40, no 1, p. 33-42
Keyword [en]
c-erbB-2, HER-2, angiogenesis, VEGF, bFGF, p53, primary breast cancer, adjuvant therapy, relapse, survival
Identifiers
URN: urn:nbn:se:umu:diva-15383DOI: doi:10.1016/S0959-8049(03)00673-7PubMedID: 14687787OAI: oai:DiVA.org:umu-15383DiVA, id: diva2:155055
Available from: 2007-09-14 Created: 2007-09-14 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Erlanson, MartinTavelin, BjörnGrankvist, KjellHenriksson, Roger

Search in DiVA

By author/editor
Erlanson, MartinTavelin, BjörnGrankvist, KjellHenriksson, Roger
By organisation
OncologyClinical chemistry

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 77 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf